Concerning the GO term adherent junctions, TCF7L2 is one of the top loci associated with increased T2D risk [90]; epigenetic modifications showed by EWAS reporting lower methylation in SAT in T2D individuals [122], and association with BMI [123] and insulin resistance [124]. The gene discussed is TCF7L2; the disease is Insulin resistance.